Ophthalmology and Optometry Coding Alert

Reader Question:

Report Toxicity Follow-Ups With E/Ms

Question: A primary care physician instructed one of our patients to see an eye doctor annually because a drug therapy she takes can affect vision. Her vision insurance doesn't cover exams annually, but her primary physician told her that her medical insurance would cover the visits due to the medication. What diagnosis should I report? We did not see her for the disease. Would that diagnosis be inappropriate? Illinois Subscriber Answer: To report a toxicity observation for a highrisk drug, you will use different codes for the baseline visit (before the patient starts the drug) and the follow-up visits to monitor the effects. For the baseline visit, report an evaluation and management code and use the ICD-9 code for the condition for which the patient will take the drug -- for example, 714.0 (Rheumatoid arthritis). If your patient had already started the medication prior to her first visit, code it as [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Ophthalmology and Optometry Coding Alert

View All